Research Summary
Analyzed using Evidence Intelligence™

Postpartum lifestyle intervention may reduce type 2 diabetes risk

Key finding

The primary objective is to assess the cumulative incidence of T2DM over a 36-month follow-up period.

This study will investigate a lifestyle intervention aimed at preventing type 2 diabetes in Asian women with a history of gestational diabetes.

Evidence strength

Moderate confidence

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Some Concerns bias
Last updated July 5, 2026

Quick read

Study at a glance

The essential study design details in one scan.

Population

Young Adult (19–39), Middle Aged (40-64), Female, Asia-Pacific (APAC), with T2 Diabetes

Intervention

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS)

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Primary outcome

Cumulative incidence of type 2 diabetes mellitus (T2DM)

Comparator

Standard postnatal care

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

This study will investigate a lifestyle intervention aimed at preventing type 2 diabetes in Asian women with a history of gestational diabetes.

Clinical relevance

Understanding how lifestyle interventions can prevent type 2 diabetes in women with a history of gestational diabetes is crucial, as this population is at increased risk. Effective strategies could lead to better long-term health outcomes for mothers and their families.

Keep in mind

Results data are pending, limiting current conclusions. The study population may not be generalizable beyond Asian women. Potential confounding factors may not be fully controlled.

Published in

Journal Reference

Publication details and source links for this paper.

Phaik LQ, He S, Wee MH, et al. Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) study. Trials. 2026. doi:10.1186/s13063-026-09516-7

Save this study and add notes to your research library.

Main Effects

The study will assess the cumulative incidence of type 2 diabetes mellitus over 36 months.

It will evaluate the incidence of prediabetes at 12-, 24-, and 36-month follow-ups.

Longitudinal changes in cardiometabolic risk factors will be monitored from 6 to 36 months.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) and Cost-effectiveness assessment, Dietary intake changes, Gestational diabetes mellitus incidence, and 2 more.

Primary intervention

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS)

Primary outcomes

  • Cost-effectiveness assessment
  • Dietary intake changes
  • Gestational diabetes mellitus incidence

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

5
Evidence pairs
5
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 68

2

Related topics

5

Evidence pairs

55

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 5 evidence relationships
  • Includes primary outcome data
  • Linked to 2 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Core evidence

Study findings

The primary outcomes reported in this study.

NoneNo Change

Cost-effectiveness assessment

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) → Cost-effectiveness assessment

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) → Cost-effectiveness assessment

Evidence profile

NoneNo ChangePatient-Reported
Unlock full evidence details
NoneNo Change

Dietary intake changes

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) → Dietary intake changes

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) → Dietary intake changes

Evidence profile

NoneNo ChangeAdherence & Engagement
Unlock full evidence details
StrongDecrease

Gestational diabetes mellitus incidence

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) → Gestational diabetes mellitus incidence

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) → Gestational diabetes mellitus incidence

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
NoneNo Change

Longitudinal changes in cardiometabolic risk factors

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) → Longitudinal changes in cardiometabolic risk factors

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) → Longitudinal changes in cardiometabolic risk factors

Evidence profile

NoneNo ChangeMetabolic Health
Unlock full evidence details
NoneNo Change

Physical activity changes

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) → Physical activity changes

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) → Physical activity changes

Evidence profile

NoneNo ChangeAdherence & Engagement
Unlock full evidence details

Unlock full evidence analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • The study will assess the cumulative incidence of type 2 diabetes mellitus over 36 months.
  • It will evaluate the incidence of prediabetes at 12-, 24-, and 36-month follow-ups.
  • Longitudinal changes in cardiometabolic risk factors will be monitored from 6 to 36 months.
keep in mind

Keep in Mind

  • Results data are pending, limiting current conclusions.
  • The study population may not be generalizable beyond Asian women.
  • Potential confounding factors may not be fully controlled.
between the lines

Between the Lines

  • Results data are pending, limiting current conclusions.
  • The study population may not be generalizable beyond Asian women.
  • Potential confounding factors may not be fully controlled.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) and Diabetes Incidence and Prevention.

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) improve gestational diabetes mellitus incidence?

Emerging Evidence

Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) appears to improve Gestational diabetes mellitus incidence.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Gestational diabetes mellitus incidence

    EvidenceScore™ Emerging | EvidenceScore™ 54.2 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) improve cost-effectiveness assessment?

Limited Evidence

Current evidence does not show a clear benefit of Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) for Cost-effectiveness assessment.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Cost-effectiveness assessment

    EvidenceScore™ Limited | EvidenceScore™ 36.6 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) improve dietary intake changes?

Limited Evidence

Current evidence does not show a clear benefit of Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) for Dietary intake changes.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Dietary intake changes

    EvidenceScore™ Limited | EvidenceScore™ 36.6 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) improve longitudinal changes in cardiometabolic risk factors?

Limited Evidence

Current evidence does not show a clear benefit of Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) for Longitudinal changes in cardiometabolic risk factors.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Longitudinal changes in cardiometabolic risk factors

    EvidenceScore™ Limited | EvidenceScore™ 36.6 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.